據報世茂(00813.HK)一筆信託展期最多16個月
《澎湃新聞》報道,世茂集團(00813.HK)旗下公司和重慶信託的一筆「重慶信託鑫虹1號集合資金信託計劃」已展期,展期期限不超過16個月。
該信託計劃現存續3期信託,其中第6期信託成立於去年2月26日,到期日爲上月26日。截至上月28日,借款人及擔保人尚未足額償還第6期信託的借款本息,現受託人決定對該信託計劃項下各期信託進行展期。
展期後,受託人將還款或信託財產變現收入,用於對信託計劃項下全部受益人進行分配。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.